Frontiers in Cardiovascular Medicine

JANUARY 28, 2025

Long COVID-19 was associated with a higher risk of thromboembolic disorders [HR 3.12 (1.60, 6.08)], coronary heart disease [HR 1.61 (1.13, 2.31)], stroke [HR 1.71 (1.07,2.72)], arrhythmia [HR 1.60 (1.13, 2.26)], cardiomyopathy [HR 1.71 (1.12, 2.61)], myocarditis [HR 6.11 (4.17,8.94)], hypertension [HR 1.70 (1.56, 1.85)], heart failure [HR 1.72 (1.15,2.59)] (..)

COVID-19 95

COVID-19 Cardiogenic Shock Cardiomyopathy Outcomes 95

Dr. Smith's ECG Blog

FEBRUARY 16, 2020

A previously healthy 53 yo woman was transferred to a receiving hospital in cardiogenic shock. I have summarized the m ajor e tiologic c ategories of acute myocarditis and inflammatory cardiomyopathies. Referring to Figure-1 — this 53-year old woman who presented in extremis with cardiogenic shock and an initial pH = 6.9,

Cardiogenic Shock 52

Cardiogenic Shock STEMI Pericarditis Blog 52

Frontiers in Cardiovascular Medicine

MAY 6, 2024

Viral myocarditis is an important cause of non-ischemic cardiomyopathy. Multiple clinical manifestations have been reported, including acute heart failure, cardiogenic shock, and ventricular arrhythmias. We present three patients with clinically suspected viral myocarditis causing acute heart failure.

Cardiogenic Shock 52

Cardiogenic Shock Heart Failure Cardiomyopathy Arrhythmia 52

Circulation: Heart Failure

APRIL 14, 2025

Circulation: Heart Failure, Ahead of Print.

Cardiogenic Shock 40

Cardiogenic Shock Heart Failure Transplant Cardiomyopathy 40

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

Female patients showed a lower prevalence rate of pre-existing coronary artery disease (48% vs. 75%, p  < 0.001) and cardiomyopathy (17% vs. 34%, p  = 0.01) compared with the male patients, while the mean age and prevalence rate of other cardiovascular risk factors were balanced.

Cardiogenic Shock 64

Cardiogenic Shock Cardiac Arrest BMI Coronary Artery Disease 64

Frontiers in Cardiovascular Medicine

FEBRUARY 19, 2024

Background Pompe disease (PD) is a rare, progressive autosomal recessive lysosomal storage disorder that directly impacts mitochondrial function, leading to structural abnormalities and potentially culminating in heart failure or cardiogenic shock. Further genetic testing identified a homozygous mutation c.2662G>T

Cardiogenic Shock 59

Cardiogenic Shock Quality of Life Heart Failure Laboratory 59

Circulation

NOVEMBER 11, 2024

A 35-year-old gravida 1, para 0 with biventricular heart failure (LVEF 25%), nonischemic cardiomyopathy, history stroke, history of left ventricular thrombus, class III obesity, and chronic kidney disease who had been followed by Cardio-Obstetrics throughout her pregnancy presented at 34 weeks gestation for planned induction of labor.

Heart Failure 40

Heart Failure Cardiogenic Shock ICU Cardiothoracic 40